Fisher & Paykel Healthcare (FRA:FPLB) Beginning Cash Position: €148 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:FPLB Fisher & Paykel Healthcare Corp Ltd FRA:FPLB
85 GF Score
Price €20.00
GF Value €21.78
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Beginning Cash Position?

Fisher & Paykel Healthcare FRA:FPLB +0.50% 85 Beginning Cash Position is €148 Mil as of Mar. 2026. GuruFocus rates FRA:FPLB with a GF Score™ of 85/100 and a GF Value™ of €21.78 (Fairly Valued). The stock has 2 warning signs investors should review.

Fisher & Paykel Healthcare's Beginning Cash Position for the quarter that ended in Mar. 2026 was €148 Mil.

Fisher & Paykel Healthcare's quarterly Beginning Cash Position increased from Mar. 2025 (€62 Mil) to Sep. 2025 (€130 Mil) and increased from Sep. 2025 (€130 Mil) to Mar. 2026 (€148 Mil).

Fisher & Paykel Healthcare's annual Beginning Cash Position declined from Mar. 2024 (€65 Mil) to Mar. 2025 (€43 Mil) but then increased from Mar. 2025 (€43 Mil) to Mar. 2026 (€132 Mil).

Fisher & Paykel Healthcare Beginning Cash Position Related Terms

Fisher & Paykel Healthcare Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Fisher & Paykel Healthcare's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Beginning Cash Position Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.26 49.05 65.36 42.86 131.62

Fisher & Paykel Healthcare Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.15 45.30 61.72 130.41 148.26
FRA:FPLB
85GF Score
Fisher & Paykel Healthcare Corp Ltd FRA:FPLB
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fisher & Paykel Healthcare Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €148 Mil mean?
Fisher & Paykel Healthcare (FRA:FPLB) has a Beginning Cash Position of €148 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Fisher & Paykel Healthcare and its competitors.
Is Fisher & Paykel Healthcare's Beginning Cash Position too high?
Fisher & Paykel Healthcare's current Beginning Cash Position is €148 Mil. Overall, Fisher & Paykel Healthcare has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Beginning Cash Position compare to ISRG and BDX?
Fisher & Paykel Healthcare's Beginning Cash Position of €148 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current Beginning Cash Position is €148 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FRA:FPLB) is currently considered Fairly Valued. The stock's GF Value™ is €21.78, compared to a current price of €20.00 — trading 8.2% below its estimated fair value. The current Beginning Cash Position is €148 Mil. Fisher & Paykel Healthcare's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FRA:FPLB), the current Beginning Cash Position is €148 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fisher & Paykel Healthcare (FRA:FPLB) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of €20.00 is trading 8.2% below its estimated GF Value™ of €21.78. GuruFocus considers Fisher & Paykel Healthcare to be Fairly Valued.

Key valuation signals for FRA:FPLB:

  • Beginning Cash Position: €148 Mil
  • GF Value™: €21.78 vs. price of €20.00 (8.2% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the FRA:FPLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fisher & Paykel Healthcare Business Description

Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
85GF Score

Get the complete analysis for FRA:FPLB

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.00
Price
€21.78
GF Value